QUOTE AND NEWS
Benzinga  Jul 10  Comment 
Medivation, Inc. (NASDAQ: MDVN) today announced Dawn Svoronos (formerly Graham) has been appointed as its chief commercial officer, reporting to David Hung, M.D., founder, chief executive officer and president of Medivation. Ms. Svoronos currently...
SeekingAlpha  Jul 10  Comment 
By Stock Doctor: When scouring biotechnology stocks to invest in, I look for undervalued companies that are developing or have approved drugs to treat diseases with high unmet clinical need with the potential to reach blockbuster status (a drug...
Motley Fool  Jul 7  Comment 
Medivation is mid-cap biopharma that looks to have a promising future based on the commercial performance of its prostate cancer drug. Here's what you need to know.
Benzinga  Jul 2  Comment 
In a report published Wednesday, Aegis Capital Corp. analyst Raghuram Selvaraju reiterated a Buy rating and $125.00 price target on Medivation (NASDAQ: MDVN). In the report, Aegis Capital Corp. noted, “Early this morning, the Swiss...
Forbes  Jun 24  Comment 
Despite small cap index Russell 2000's generally neutral performance in 2014 thus far, there is still a portion of that index's components that is very much worth investor's money and attention, says an analyst at Citi. Top picks include 3D...
Benzinga  Jun 19  Comment 
Analysts at RBC Capital upgraded FedEx (NYSE: FDX) from “underperform” to “sector perform.” The target price for FedEx has been raised from $125 to $155. FedEx's shares closed at $148.95 yesterday. Analysts at Jefferies upgraded...
DailyFinance  Jun 16  Comment 
SAN FRANCISCO, CA -- (Marketwired) -- 06/16/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that for the second year in a row it was named among the top mid-sized companies in the San Francisco Bay Area News Group's annual Top Workplaces...
Benzinga  May 22  Comment 
Analysts at Morgan Stanley initiated coverage on shares of The AES (NYSE: AES) with an “equal-weight” rating. The target price for AES is set to $15. AES's shares closed at $13.58 yesterday. FBR Capital initiated coverage on shares of The...
StreetInsider.com  May 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Medivation+%28MDVN%29+Says+Enzalutamide+Data+to+Be+Presented+at+ASCO/9486829.html for the full story.
SeekingAlpha  May 9  Comment 
Medivation (MDVN) Q1 2014 Earnings Call May 08, 2014 4:30 pm ET Executives Anne Bowdidge - Senior Director of Investor Relations David T. Hung - Chief Executive Officer, President and Executive Director Rick Bierly - Chief...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki